Pfizer (PFE) closed the latest trading day at $25.23, indicating a -1.33% change from the previous session's end. The stock's change was less than the S&P 500's daily gain of 0.82%. Meanwhile, the Dow ...

Check the time stamp on this data. Updated AI-Generated Signals for Pfizer Inc. (PFE) available here: PFE.

We recently compiled a list of the 8 Best American Dividend Stocks To Buy Right Now. In this article, we are going to take a ...

In a report released today, Umer Raffat from Evercore ISI maintained a Buy rating on Pfizer (PFE – Research Report). The company’s shares ...

Pfizer has a diversified portfolio, including successful vaccines and promising new drugs. Read more to see why I upgrade PFE ...

Guggenheim lowered the firm’s price target on Pfizer (PFE) to $33 from $35 and keeps a Buy rating on the shares. Pfizer will be releasing their ...

Health care companies are taking a step back to better understand patients' experiences after a powerful U.S. health ...

PFE has been the subject of a number of recent research reports ... Pfizer’s payout ratio is currently 227.03%. In other news, Director Scott Gottlieb acquired 1,000 shares of the business’s stock in ...

We recently published a list of 12 Best Affordable Stocks To Buy Right Now. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best affordable stocks to ...

PFE has been the topic of several analyst reports ... antiviral products under the Comirnaty and Paxlovid brands. Receive News & Ratings for Pfizer Daily - Enter your email address below to ...

This page features the latest news about the Pfizer DRC stock. Pfizer offloads $3.3 billion stake in Sensodyne-maker Haleon (Reuters) - Pfizer (NYSE:PFE) offloaded shares worth roughly $3.26 ...